Stay updated on Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0; the previous Revision: v3.4.3 label was removed.
    Difference
    0.1%
    Check dated 2026-03-25T20:31:47.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updated from v3.4.2; no user-facing content changes detected.
    Difference
    0.1%
    Check dated 2026-03-11T15:48:53.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Publications section added with a cited Oncoimmunology article and a note that these items are auto-filled from PubMed. This contextual information does not alter the trial details, eligibility criteria, or study design on the page.
    Difference
    0.3%
    Check dated 2026-03-04T11:33:07.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T04:50:36.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    A government funding status notice was added and the page revision tag updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T03:31:40.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    The page adds a glossary display and updates QC-related metadata, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the older labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:40:30.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.